Cargando…
Epidemiology and Antifungal Susceptibility Profile of Aspergillus Species: Comparison between Environmental and Clinical Isolates from Patients with Hematologic Malignancies
Global data on the epidemiology and susceptibility of Aspergillus are crucial in the management of invasive aspergillosis. Here, we aimed to determine the characteristics of clinical and environmental Aspergillus isolates, focusing mainly on hematologic malignancy patients. We prospectively collecte...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595445/ https://www.ncbi.nlm.nih.gov/pubmed/31018982 http://dx.doi.org/10.1128/JCM.02023-18 |
_version_ | 1783430404529717248 |
---|---|
author | Cho, Sung-Yeon Lee, Dong-Gun Kim, Won-Bok Chun, Hye-Sun Park, Chulmin Myong, Jun-Pyo Park, Yeon-Joon Choi, Jae-Ki Lee, Hyo-Jin Kim, Si-Hyun Park, Sun Hee Choi, Su-Mi Choi, Jung-Hyun Yoo, Jin-Hong |
author_facet | Cho, Sung-Yeon Lee, Dong-Gun Kim, Won-Bok Chun, Hye-Sun Park, Chulmin Myong, Jun-Pyo Park, Yeon-Joon Choi, Jae-Ki Lee, Hyo-Jin Kim, Si-Hyun Park, Sun Hee Choi, Su-Mi Choi, Jung-Hyun Yoo, Jin-Hong |
author_sort | Cho, Sung-Yeon |
collection | PubMed |
description | Global data on the epidemiology and susceptibility of Aspergillus are crucial in the management of invasive aspergillosis. Here, we aimed to determine the characteristics of clinical and environmental Aspergillus isolates, focusing mainly on hematologic malignancy patients. We prospectively collected all consecutive cases and clinical isolates of culture-positive proven/probable invasive aspergillosis patients from January 2016 to April 2018 and sampled the air inside and outside the hospital. Cryptic species-level identification of Aspergillus, antifungal susceptibilities, and cyp51 gene sequencing were performed, and clinical data were analyzed. This study was conducted as part of the Catholic Hematology Hospital Fungi Epidemiology (CAFÉ) study. A total of 207 proven/probable invasive aspergillosis and 102 clinical and 129 environmental Aspergillus isolates were included in this analysis. The incidence of proven/probable invasive aspergillosis was 1.3 cases/1,000 patient-days during the study period. Cryptic Aspergillus species accounted for 33.8%, with no differences in proportions between the clinical and environmental isolates. Section Nigri presented a high proportion (70.5%) of cryptic species, mainly from A. tubingensis and A. awamori: the former being dominant in environmental samples, and the latter being more common in clinical isolates (P < 0.001). Of 91 A. fumigatus isolates, azole-resistant A. fumigatus was found in 5.3% of all A. fumigatus isolates. Three isolates presented the TR(34)/L98H mutation of the cyp51A gene. Patients with invasive aspergillosis caused by azole-resistant A. fumigatus showed 100% all-cause mortality at 100 days. This study demonstrates the significant portion of cryptic Aspergillus species and clinical implications of azole resistance and underscores the comparison between clinical and environmental isolates. |
format | Online Article Text |
id | pubmed-6595445 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | American Society for Microbiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-65954452019-07-17 Epidemiology and Antifungal Susceptibility Profile of Aspergillus Species: Comparison between Environmental and Clinical Isolates from Patients with Hematologic Malignancies Cho, Sung-Yeon Lee, Dong-Gun Kim, Won-Bok Chun, Hye-Sun Park, Chulmin Myong, Jun-Pyo Park, Yeon-Joon Choi, Jae-Ki Lee, Hyo-Jin Kim, Si-Hyun Park, Sun Hee Choi, Su-Mi Choi, Jung-Hyun Yoo, Jin-Hong J Clin Microbiol Mycology Global data on the epidemiology and susceptibility of Aspergillus are crucial in the management of invasive aspergillosis. Here, we aimed to determine the characteristics of clinical and environmental Aspergillus isolates, focusing mainly on hematologic malignancy patients. We prospectively collected all consecutive cases and clinical isolates of culture-positive proven/probable invasive aspergillosis patients from January 2016 to April 2018 and sampled the air inside and outside the hospital. Cryptic species-level identification of Aspergillus, antifungal susceptibilities, and cyp51 gene sequencing were performed, and clinical data were analyzed. This study was conducted as part of the Catholic Hematology Hospital Fungi Epidemiology (CAFÉ) study. A total of 207 proven/probable invasive aspergillosis and 102 clinical and 129 environmental Aspergillus isolates were included in this analysis. The incidence of proven/probable invasive aspergillosis was 1.3 cases/1,000 patient-days during the study period. Cryptic Aspergillus species accounted for 33.8%, with no differences in proportions between the clinical and environmental isolates. Section Nigri presented a high proportion (70.5%) of cryptic species, mainly from A. tubingensis and A. awamori: the former being dominant in environmental samples, and the latter being more common in clinical isolates (P < 0.001). Of 91 A. fumigatus isolates, azole-resistant A. fumigatus was found in 5.3% of all A. fumigatus isolates. Three isolates presented the TR(34)/L98H mutation of the cyp51A gene. Patients with invasive aspergillosis caused by azole-resistant A. fumigatus showed 100% all-cause mortality at 100 days. This study demonstrates the significant portion of cryptic Aspergillus species and clinical implications of azole resistance and underscores the comparison between clinical and environmental isolates. American Society for Microbiology 2019-06-25 /pmc/articles/PMC6595445/ /pubmed/31018982 http://dx.doi.org/10.1128/JCM.02023-18 Text en Copyright © 2019 Cho et al. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Mycology Cho, Sung-Yeon Lee, Dong-Gun Kim, Won-Bok Chun, Hye-Sun Park, Chulmin Myong, Jun-Pyo Park, Yeon-Joon Choi, Jae-Ki Lee, Hyo-Jin Kim, Si-Hyun Park, Sun Hee Choi, Su-Mi Choi, Jung-Hyun Yoo, Jin-Hong Epidemiology and Antifungal Susceptibility Profile of Aspergillus Species: Comparison between Environmental and Clinical Isolates from Patients with Hematologic Malignancies |
title | Epidemiology and Antifungal Susceptibility Profile of Aspergillus Species: Comparison between Environmental and Clinical Isolates from Patients with Hematologic Malignancies |
title_full | Epidemiology and Antifungal Susceptibility Profile of Aspergillus Species: Comparison between Environmental and Clinical Isolates from Patients with Hematologic Malignancies |
title_fullStr | Epidemiology and Antifungal Susceptibility Profile of Aspergillus Species: Comparison between Environmental and Clinical Isolates from Patients with Hematologic Malignancies |
title_full_unstemmed | Epidemiology and Antifungal Susceptibility Profile of Aspergillus Species: Comparison between Environmental and Clinical Isolates from Patients with Hematologic Malignancies |
title_short | Epidemiology and Antifungal Susceptibility Profile of Aspergillus Species: Comparison between Environmental and Clinical Isolates from Patients with Hematologic Malignancies |
title_sort | epidemiology and antifungal susceptibility profile of aspergillus species: comparison between environmental and clinical isolates from patients with hematologic malignancies |
topic | Mycology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595445/ https://www.ncbi.nlm.nih.gov/pubmed/31018982 http://dx.doi.org/10.1128/JCM.02023-18 |
work_keys_str_mv | AT chosungyeon epidemiologyandantifungalsusceptibilityprofileofaspergillusspeciescomparisonbetweenenvironmentalandclinicalisolatesfrompatientswithhematologicmalignancies AT leedonggun epidemiologyandantifungalsusceptibilityprofileofaspergillusspeciescomparisonbetweenenvironmentalandclinicalisolatesfrompatientswithhematologicmalignancies AT kimwonbok epidemiologyandantifungalsusceptibilityprofileofaspergillusspeciescomparisonbetweenenvironmentalandclinicalisolatesfrompatientswithhematologicmalignancies AT chunhyesun epidemiologyandantifungalsusceptibilityprofileofaspergillusspeciescomparisonbetweenenvironmentalandclinicalisolatesfrompatientswithhematologicmalignancies AT parkchulmin epidemiologyandantifungalsusceptibilityprofileofaspergillusspeciescomparisonbetweenenvironmentalandclinicalisolatesfrompatientswithhematologicmalignancies AT myongjunpyo epidemiologyandantifungalsusceptibilityprofileofaspergillusspeciescomparisonbetweenenvironmentalandclinicalisolatesfrompatientswithhematologicmalignancies AT parkyeonjoon epidemiologyandantifungalsusceptibilityprofileofaspergillusspeciescomparisonbetweenenvironmentalandclinicalisolatesfrompatientswithhematologicmalignancies AT choijaeki epidemiologyandantifungalsusceptibilityprofileofaspergillusspeciescomparisonbetweenenvironmentalandclinicalisolatesfrompatientswithhematologicmalignancies AT leehyojin epidemiologyandantifungalsusceptibilityprofileofaspergillusspeciescomparisonbetweenenvironmentalandclinicalisolatesfrompatientswithhematologicmalignancies AT kimsihyun epidemiologyandantifungalsusceptibilityprofileofaspergillusspeciescomparisonbetweenenvironmentalandclinicalisolatesfrompatientswithhematologicmalignancies AT parksunhee epidemiologyandantifungalsusceptibilityprofileofaspergillusspeciescomparisonbetweenenvironmentalandclinicalisolatesfrompatientswithhematologicmalignancies AT choisumi epidemiologyandantifungalsusceptibilityprofileofaspergillusspeciescomparisonbetweenenvironmentalandclinicalisolatesfrompatientswithhematologicmalignancies AT choijunghyun epidemiologyandantifungalsusceptibilityprofileofaspergillusspeciescomparisonbetweenenvironmentalandclinicalisolatesfrompatientswithhematologicmalignancies AT yoojinhong epidemiologyandantifungalsusceptibilityprofileofaspergillusspeciescomparisonbetweenenvironmentalandclinicalisolatesfrompatientswithhematologicmalignancies |